Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase ( FH ) as pathogenic
Genes, Chromosomes and Cancer · 2024
DOI: 10.1002/gcc.23221 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2024. Verfasst von Lydia Ouchene und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Fumarate Hydratase, Mutation, Missense, Leiomyomatosis, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant cancer predisposition syndrome characterized by cutaneous leiomyomas, uterine leiomyomas, and aggressive renal cancer. Germline variants in the fumarate hydratase ( FH ) gene predispose to HLRCC. Identifying germline pathogenic FH variants enables lifetime renal cancer screening and genetic testing for family members. In this report, we present a FH missense variant (c.1039T>C (p.S347P)), initially classified as a variant of uncertain significance. Clinical assessment, histopathological findings, molecular genetic studies, and enzymatic activity studies support the re‐classification of the FH c.1039T>C variant to “pathogenic” based on ACMG/AMP criteria. Further insights into pathological recognition of FH‐deficient renal cancer are discussed and should be recognized. This study has shown how (a) detailed multi‐disciplinary analyses of a single variant can reclassify rare missense variants in FH and (b) careful pathological review of renal cancers is obligatory when HLRCC is suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada.
- Division of Dermatology, Department of Medicine, McGill University, Montréal, Québec, Canada.
- Department of Biological Chemistry, University of California Los Angeles, Los Angeles, California, USA.
- Jonnson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.
- Department of Human Genetics, McGill University, Montréal, Québec, Canada.
- Cancer Research Program, Centre for Translational Biology, The Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
ORCID-Profile: Lydia Ouchene, Jose Camacho Valenzuela, William D Foulkes
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Ouchene, L., Wilde, B., Chan-Pak-Choon, F., Camacho Valenzuela, J., Brimo, F., Witkowski, L., Christofk, H., Domecq, C., Fu, L., Weber, E., Lemieux Anglin, B., Netchiporouk, E., & Foulkes, W. D. (2024). Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase ( FH ) as pathogenic. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23221
Vancouver
Ouchene L, Wilde B, Chan-Pak-Choon F, Camacho Valenzuela J, Brimo F, Witkowski L, et al. Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase ( FH ) as pathogenic. Genes, Chromosomes and Cancer. 2024. doi:10.1002/gcc.23221
BibTeX
@article{Ouchene2024,
author = {Ouchene, Lydia and Wilde, Blake and Chan-Pak-Choon, Fiona and Camacho Valenzuela, Jose and Brimo, Fadi and Witkowski, Leora and Christofk, Heather and Domecq, Celine and Fu, Lili and Weber, Evan and Lemieux Anglin, Brianna and Netchiporouk, Elena and Foulkes, William D},
title = {Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase ( FH ) as pathogenic},
journal = {Genes, Chromosomes and Cancer},
year = {2024},
doi = {10.1002/gcc.23221}
}
EUVIMED